Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll CD8+ T cells in Trypanosoma cruzi infection Padilla AM; Bustamante JM; Tarleton RLCurr Opin Immunol 2009[Aug]; 21 (4): 385-90CD8(+) T cells have emerged as crucial players in the control of a number of protozoan pathogens, including Trypanosoma cruzi, the agent of human Chagas disease. The recent identification of the dominant targets of T. cruzi-specific T cells has allowed investigators to follow the generation of and document the functionality of T cell responses in both mice and humans. Although slow to develop in the early stages of the infection, T. cruzi-specific CD8(+) T cells reach prodigious levels and remain highly functional throughout chronic infections in mice. Following drug-induced cure during either the acute or chronic stage, these immunodominant T cells persist as stable, antigen-independent memory populations. T. cruzi-specific CD8(+) T cells in humans are less-well-studied but appear to lose functionality and decline in numbers in these decades-long infections. Changes in the frequency of parasite-specific T cell upon therapeutic treatment in humans may provide a new metric for determining treatment efficacy.|Animals[MESH]|CD8-Positive T-Lymphocytes/*immunology/pathology[MESH]|Chagas Disease/diagnosis/*immunology/pathology/physiopathology/therapy[MESH]|Disease Progression[MESH]|Humans[MESH]|Immunodominant Epitopes/immunology[MESH]|Immunologic Memory[MESH]|Mice[MESH]|Prognosis[MESH]|Treatment Outcome[MESH]|Trypanosoma cruzi/growth & development/*immunology/pathogenicity[MESH] |